Literature DB >> 25083251

Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies.

David Madigan1, Patrick B Ryan2, Martijn Schuemie3.   

Abstract

BACKGROUND: Clinical studies that use observational databases, such as administrative claims and electronic health records, to evaluate the effects of medical products have become commonplace. These studies begin by selecting a particular study design, such as a case control, cohort, or self-controlled design, and different authors can and do choose different designs for the same clinical question. Furthermore, published papers invariably report the study design but do not discuss the rationale for the specific choice. Studies of the same clinical question with different designs, however, can generate different results, sometimes with strikingly different implications. Even within a specific study design, authors make many different analytic choices and these too can profoundly impact results. In this paper, we systematically study heterogeneity due to the type of study design and due to analytic choices within study design. METHODS AND
FINDINGS: We conducted our analysis in 10 observational healthcare databases but mostly present our results in the context of the GE Centricity EMR database, an electronic health record database containing data for 11.2 million lives. We considered the impact of three different study design choices on estimates of associations between bisphosphonates and four particular health outcomes for which there is no evidence of an association. We show that applying alternative study designs can yield discrepant results, in terms of direction and significance of association. We also highlight that while traditional univariate sensitivity analysis may not show substantial variation, systematic assessment of all analytical choices within a study design can yield inconsistent results ranging from statistically significant decreased risk to statistically significant increased risk. Our findings show that clinical studies using observational databases can be sensitive both to study design choices and to specific analytic choices within study design.
CONCLUSION: More attention is needed to consider how design choices may be impacting results and, when possible, investigators should examine a wide array of possible choices to confirm that significant findings are consistently identified.

Entities:  

Keywords:  analysis; health outcomes; healthcare database; study design

Year:  2013        PMID: 25083251      PMCID: PMC4110833          DOI: 10.1177/2042098613477445

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  25 in total

1.  Design considerations in an active medical product safety monitoring system.

Authors:  Joshua J Gagne; Bruce Fireman; Patrick B Ryan; Malcolm Maclure; Tobias Gerhard; Sengwee Toh; Jeremy A Rassen; Jennifer C Nelson; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

2.  Comparison of GE Centricity Electronic Medical Record database and National Ambulatory Medical Care Survey findings on the prevalence of major conditions in the United States.

Authors:  Albert G Crawford; Christine Cote; Joseph Couto; Mehmet Daskiran; Candace Gunnarsson; Kara Haas; Sara Haas; Somesh C Nigam; Rob Schuette; Joseph Yaskin
Journal:  Popul Health Manag       Date:  2010-06       Impact factor: 2.459

3.  An analysis of the exclusion criteria used in observational pharmacoepidemiological studies.

Authors:  Michael Perrio; Patrick C Waller; Saad A W Shakir
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-03       Impact factor: 2.890

4.  The self controlled case series method.

Authors:  Heather Whitaker
Journal:  BMJ       Date:  2008-08-28

5.  Use of statins and risk of fractures.

Authors:  T P van Staa; S Wegman; F de Vries; B Leufkens; C Cooper
Journal:  JAMA       Date:  2001-04-11       Impact factor: 56.272

6.  A collection of 56 topics with contradictory results in case-control research.

Authors:  L C Mayes; R I Horwitz; A R Feinstein
Journal:  Int J Epidemiol       Date:  1988-09       Impact factor: 7.196

Review 7.  Bisphosphonates and esophageal cancer--a pathway through the confusion.

Authors:  William G Dixon; Daniel H Solomon
Journal:  Nat Rev Rheumatol       Date:  2011-05-03       Impact factor: 20.543

8.  Quality of lipid management in outpatient care: a national study using electronic health records.

Authors:  James M Gill; Yingxia Chen
Journal:  Am J Med Qual       Date:  2008 Sep-Oct       Impact factor: 1.852

9.  Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis.

Authors:  Anthony Grosso; Ian Douglas; Aroon Hingorani; Raymond MacAllister; Liam Smeeth
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

10.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

View more
  9 in total

1.  Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.

Authors:  Paul E Stang; Patrick B Ryan; J Marc Overhage; Martijn J Schuemie; Abraham G Hartzema; Emily Welebob
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

2.  The emerging landscape of health research based on biobanks linked to electronic health records: Existing resources, statistical challenges, and potential opportunities.

Authors:  Lauren J Beesley; Maxwell Salvatore; Lars G Fritsche; Anita Pandit; Arvind Rao; Chad Brummett; Cristen J Willer; Lynda D Lisabeth; Bhramar Mukherjee
Journal:  Stat Med       Date:  2019-12-20       Impact factor: 2.373

3.  Atypical Antipsychotics and the Risks of Acute Kidney Injury and Related Outcomes Among Older Adults: A Replication Analysis and an Evaluation of Adapted Confounding Control Strategies.

Authors:  Patrick B Ryan; Martijn J Schuemie; Darmendra Ramcharran; Paul E Stang
Journal:  Drugs Aging       Date:  2017-03       Impact factor: 3.923

4.  Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications.

Authors:  Stylianos Serghiou; Chirag J Patel; Yan Yu Tan; Peter Koay; John P A Ioannidis
Journal:  J Clin Epidemiol       Date:  2015-09-28       Impact factor: 6.437

5.  Feasibility and utility of applications of the common data model to multiple, disparate observational health databases.

Authors:  Erica A Voss; Rupa Makadia; Amy Matcho; Qianli Ma; Chris Knoll; Martijn Schuemie; Frank J DeFalco; Ajit Londhe; Vivienne Zhu; Patrick B Ryan
Journal:  J Am Med Inform Assoc       Date:  2015-02-10       Impact factor: 4.497

6.  Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales).

Authors:  Connor A Emdin; Allan J Hsiao; Amit Kiran; Nathalie Conrad; Gholamreza Salimi-Khorshidi; Mark Woodward; Simon G Anderson; Hamid Mohseni; John J V McMurray; John G F Cleland; Henry Dargie; Suzanna Hardman; Theresa McDonagh; Kazem Rahimi
Journal:  Am J Cardiol       Date:  2016-11-01       Impact factor: 2.778

7.  Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record-Derived Real-World Data.

Authors:  Katherine Tan; Jonathan Bryan; Brian Segal; Lawrence Bellomo; Nate Nussbaum; Melisa Tucker; Aracelis Z Torres; Carrie Bennette; William Capra; Melissa Curtis; Rebecca A Miksad
Journal:  Clin Pharmacol Ther       Date:  2021-07-31       Impact factor: 6.903

8.  Computational drug repositioning of atorvastatin for ulcerative colitis.

Authors:  Lawrence Bai; Madeleine K D Scott; Ethan Steinberg; Laurynas Kalesinskas; Aida Habtezion; Nigam H Shah; Purvesh Khatri
Journal:  J Am Med Inform Assoc       Date:  2021-10-12       Impact factor: 4.497

9.  Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases.

Authors:  M Lavallee; T Yu; L Evans; M Van Hemelrijck; C Bosco; A Golozar; A Asiimwe
Journal:  BMC Med Inform Decis Mak       Date:  2022-02-03       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.